The Accuracy of Computed Tomography in the Pretreatment T and N Staging of Colorectal Cancer by Simoglou, Christos S
The Accuracy of Computed Tomography 
in the Pretreatment T and N Staging  
of Colorectal Cancer
Christos S. Simoglou, MD,1 Dimitrios Tsolakidis, MD,2  
Ioannis Papadopoulos, MD3
A b s t r A c t
Computed tomography (CT) is a widely used detection and staging modality for colo-
rectal cancer patients in clinical practice. The role of CT in assessing patients with 
colorectal cancer has been well established, but the accuracy of evaluating and staging 
the colorectal cancer by CT varies in different reports. With the development of CT 
techniques, some reformations such as multi-detector CT, CT with water enema or air 
insufflations, and multiple planner reconstruction help to give us higher resolution 
images in shorter time. CT is playing an increasingly important role in pretreatment 
staging of colorectal cancer, although magnetic resonance imaging and endorectal 
ultrasound (also called transrectal ultrasound) may provide more precise images and 
evaluation of local T and N staging of rectal cancer. Finally, positron emission tomog-
raphy (PET) or PET/CT have not shown any significant improvement after comple-
tion of standard pretreatment evaluation.
I n t r o d u c t I o n
Colorectal cancer is the third most common malignant tumor and the third leading 
cause of cancer-related death in Western countries.1 According to the Surveillance, 
Epidemiology, and End Results (SEER) program of the National Cancer Institute 
long-term reports (beginning in 1973), the mortality of colorectal cancer from 2005 
to 2009 was 20.2 in males and 14.1 in females per 100,000, and the incidence was 
54.0 (males) and 40.3 (females) per 100,000.2 It is gratifying that there was a decline 
of colorectal cancer incidence rates over the last 5 years, and this should be largely 
attributed to early screening, which could allow early diagnosis and removal of precan-
cerous polyps.3-5 With the development of multimodality therapies including surgery, 
chemotherapy, radiotherapy and targeted therapy, the 1-year and 5-year relative survival 
rates of colorectal cancer are 83.2% and 64.3%, respectively.6 For colorectal cancers 
detected at a localized stage, the 5-year relative survival rate is 90.1%. If cancer has 
spread regionally to involve adjacent organs or lymph nodes, the 5-year survival rate 
decreases to 69.2%. What appears to be worse, if the disease has spread to distant 
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organs, is the 5-year survival rate which is only 11.7%.6 So 
an early and accurate detection of colorectal cancer is very 
important, and a precise tumor staging can help physicians to 
predict the patients’ mean residual life on which the clinical 
decision is based.
The purpose of this review is to summarize the pretreat-
ment T and N staging accuracy of CT relative to pathological 
examination, and compare the diverse results of different CT 
equipment with various parameters and preparations, and thus 
determine the value of CT for pretreatment colorectal cancer 
staging and recommend the best CT parameters and prepa-
rations in clinical practice. By stating the deficiencies of CT 
staging and comparing CT with magnetic resonance imaging 
(MRI), endorectal ultrasound (ERUS) and positron emission 
tomography (PET)/CT, we could give a recommendation for 
the pretreatment imaging modality choice.
t h e  A d v A n t A g e s  o f  c t  s t A g I n g
The American College of Radiology recommends en-
hanced CT as the first choice for the pretreatment staging of 
colonic or rectal cancers. Indeed, compared with MRI or other 
imaging modalities, CT has its own irreplaceable advantages.
First of all, CT is a non-invasive modality to obtain a rapid 
overall assessment, not only of regional lesions, but also of 
distant metastases. For example, with a CT scan of the abdo-
men, we could obtain images of not only the bowel lesion, but 
also of some other main organs including liver, pancreas, gall 
bladder, lymph nodes and so on. Though PET could provide 
whole body images, PET alone could not offer images clear 
enough for evaluation.
Secondly, CT could acquire all the images in less than one 
minute, while MRI could only acquire part of the abdominal 
images in several minutes, sometimes more than ten minutes. 
Thus, cancer patients in some busy hospitals would prefer CT 
as the pretreatment evaluation rather than MRI which would 
require patients to wait for several days to have it scheduled.
Thirdly, fast scan of CT would reduce the image artifacts 
caused by breath and bowel peristalsis. The image artifact is 
really a problem with MRI, because even though patients can 
hold their breath for a long time, the bowels are still moving, 
which would influence the accuracy of the scan. This is the 
reason why the colon is rarely evaluated with MRI.
Fourthly, CT images could be well retained for comparison 
of pretreatment and post-treatment tumor size, as well as the 
lymph node size or other benign and malignant nodules.
Finally, with advances in CT technology and comput-
ing software, such as CT angiography, the post-processing 
computed reconstruction techniques including multiplanar 
reconstruction (MPR), volume rendering technique, CT colon-
oscopy (CTC) and so on, make CT more helpful to precise 
diagnosis of lesions.8,9 CT colonoscopy is especially beneficial 
after incomplete colonoscopy to evaluate the remainder of the 
colon and is currently being advocated in some countries as a 
screening tool.10 For avoidance of uncomfortable colonoscopy 
experience, more than 95% of patients prefer CTC to routine 
colono{Duman, 2012 #57}scopy.11 Also, 64-slice, 128-slice, or 
even 320-slice CT scanners provide us with higher resolution 
images in shorter time associated with less radiation exposure.12
d I A g n o s t I c  A c c u r A c y  o f  c t  
I n  t  s t A g I n g
Nowadays, the Tumor Node Metastasis (TNM) classifica-
tion is used worldwide for the staging of colorectal cancer.13 
In some early studies, Dukes’ classification was more often 
used.14,15 Here we firstly focus on the T staging of TNM clas-
sification.
As with different kinds of CT scanners, experience of op-
erators, parameters of CT and so on, the T staging accuracy 
of CT varies in different studies.
The most important reason why CT staging may not so 
correctly correspond to the histopathological T staging may 
be the difficulty to differentiate bowel wall layers. Without 
the improved spatial resolution of multi detector CT (MDCT) 
scanning, it is really a tough problem to differentiate the 
mucosa, submucosa, muscularis propria, serosa and visceral 
peritoneum with conventional single row CT. The commonly 
used criteria modified by Smith et al and Burton et al for tumor 
staging of MDCT recommended intraluminal projection of a 
colonic lesion without any visible distortion of the wall layers 
as T1 stage,16 and T2 stage was recommended as asymmetrical 
thickening projecting intraluminally and smooth preservation 
of muscle coat and clear adjacent pericolic fat, but the inability 
to distinguish between T1 and T2 lesions was still a known 
limitation for CT.17-20
In a recent study,21 even though the section thickness was 
as thin as 0.5 mm, the MDCT only correctly staged 45 local 
tumors of 73 in total, compared with the histopathological 
examination, with the best accuracy of 74% in T2 stage. The 
sensitivity for T4 is 0 in 6, which means all 6 tumors were 
understaged. Also, a similar trend of results was shown in 
another study which acquired images with a collimation of 5 
mm and 7 mm;20 the accuracy of T2, T3, T4 gradually decreased 
from 60% to 25% in 99 tumors, and 75% of T4 tumors were 
understaged. T4-stage tumors could be easily understaged to 
T3, for some microscopic invasions penetrating the bowel wall 
and infiltrating adjacent tissues which could only be confirmed 
on pathological examination were tough to recognize on CT 
images. On the other hand, the T3 stage tumors which ap-
peared to be an involvement of the adjacent bowel could be 
easily overstaged to T4 stage.
Additionally, it is always difficult to differentiate inflam-
matory or desmoplastic reaction from true transmural spread. 
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Small strands of tumor tissue in pericolic fat on CT images may 
give clues in differentiating T2 from T3 stage. These strands 
may indicate tumoral involvement in the pericolic fat or serosa. 
Fibrosis, inflammation or congestive changes may also result in 
these strand images. So the peritumoral reaction consisting of 
fibrosis and inflammation is an important cause of overstaging.
Therefore, how can we make tumor depth of invading the 
bowel wall layers easier to be recognized by the radiologists? 
How can we have the thickened intestinal wall get caught by 
the radiologists’ first sight?
1 .  t h e  c h o I c e  o f  M d c t  A n d  t h e  s e c t I o n 
t h I c K n e s s  o f  c t
The choice of MDCT and the section thickness of CT are 
important for the evaluation of T staging. Some early stud-
ies demonstrated a sensitivity of 55-61% for tumor invasion 
beyond muscularis propria (MP),14,22,23 which was equivalent 
to T3 or T4 stage according to the TNM classification, and 
specificity of 67-81%, compared with the histopathological 
findings. Such a low sensitivity, in other words such a high false 
negative rate, should be attributed to use of conventional CT 
scanners instead of spiral or MDCT and with a section thick-
ness of 10 mm. The poor image quality combined with 10 mm 
section thickness may be the most likely reason of failure to 
detect the small amount of tumor lesions or the microscopic 
invasion beyond the MP.
A section thickness of 10 mm may produce more image 
artifacts than the thinner one, and the image artifacts may be 
the result of the partial volume effects, which can be defined 
as the loss of apparent activity in small objects or regions be-
cause of the limited resolution of the imaging system. Partial 
volume artifacts can be minimized by using a thin acquisition 
section width.24 In recent years, with the utilization of spiral 
CT or MDCT and the section thickness of 5 mm or less, the 
sensitivity of detecting tumor invasion beyond MP increased 
to 80-100%, with a specificity of 75-91%.25-27
An excellent meta-analysis performed by Dighe et al 
provided a considerable pooled result and a serious subgroup 
analysis which concern many factors that may affect the pooled 
result.17 In the subgroup analysis of the total 19 studies with 
907 patients, one of the best subgroup results for detection of 
tumor invasion beyond MP was obtained in studies that utilized 
CT section thicknesses of 5 mm or less (sensitivity of 95%, 
specificity of 84%, diagnostic odds ratio, DOR 95.3), compared 
to the pooled sensitivity, specificity, DOR (86%, 78%, 22.4) of 
the total 19 studies. The subgroup results obtained in studies 
utilizing MDCT (sensitivity of 93%, specificity of 86%, DOR 
83.5) were also excellent, significantly higher than those on aver-
age. Thus, MDCT with thinner section thickness could help the 
radiologists achieve more accurate pretreatment tumor staging.
2 .  M u l t I p l A n A r  r e f o r M A t I o n s
Multiplanar reformations (MPR) are two-dimensional 
reformatted images that are reconstructed secondarily in ar-
bitrary planes from the stack of axial image data. MDCT with 
MPR allows improved visualization of the bowel in all direc-
tions. The evaluation of axial in combination with MPR could 
help to improve the staging accuracy.18 In a study evaluating 
the accuracy of contrast-enhanced MDCT for preoperative T 
staging,19 when transverse images were evaluated alone, the 
overall accuracy was 73% (30 of 41 patients), but the accuracy 
improved to 83% (34 of 41 patients) when transverse and 
MPR images were evaluated in combination. Similar results 
were obtained in another study,9 which were identified by two 
radiologists when differentiating ≤T3 from T4, whereby the 
specificity was significantly increased by using the combined 
axial and MPR data sets, compared with that of using axial 
data sets only. On the other hand, MPR images in the standard 
sagittal and coronal planes are readily generated with no ad-
ditional radiation exposure for patients and with no additional 
labor or time required on the part of the radiologists. Thus, 
MPR may be an important technique that can improve the 
staging accuracy.
3 .  A d e q u A t e  b o w e l  p r e pA r A t I o n  
A n d  d I s t e n t I o n
Adequate bowel preparation and distention may also be 
of some help. The thickness of the normal bowel wall varies 
slightly depending on the degree of luminal distention. If the 
colon is well distended, the wall thickness should be measured 
to less than 3 mm, which is often imperceptible.28 Frequently, 
because of fecal contents, fluid, or colonic redundancy, the true 
thickness is difficult to ascertain. In the pretreatment tumor 
staging, it is necessary to have a well distended bowel. The 
main ways are air insufflation of the colon or utilizing water 
enema, which means a bag of water or air would be gently 
infused into the rectum through a lubricated enema tube or 
by a special machine.
Air insufflation of the colon waw first introduced by 
Megibow et al as an adjunct to CT of the pelvis in 1984,29 then 
water enema was used in CT for imaging the colon cancers 
by Angelelli and Macarini in 1988.30 Colonic preparation and 
distension with air or water contribute to the improvement 
of the obtained results, as exemplified by Balthazar et al.15,23 
In the subgroup analysis of the meta-analysis performed by 
Dighe,17 the 95% sensitivity and the 86% specificity obtained 
in the subgroup of using rectal insufflation either with air or 
water was optimal, and the DOR (104.5) was the highest one 
among the subgroups. These results gave us a valid support 
that CT with water enema (WE-CT) or air insufflation was a 
helpful technique in pretreatment staging of colorectal cancer. 
Some early studies using Dukes’ classification indicated that 
compared to the pathological staging, the colorectal cancer 
staging accuracy of WE-CT varies between 77% and 84%.25,31 
These data need larger sample size studies to get confirmed 
because this technique has not been widely used in clinic so 
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far. Perhaps the major limitation of WE-CT was that water 
enema can be difficult and distressing in frail elderly patients 
and would have the risk of water incontinence.
CT imaging with pneumocolon, which means air insuffla-
tion of the colon, could clearly show the lumen and wall of 
the colon and colonic lesions, on which the thickness of the 
normal colonic wall ranged 1-2 mm.32 The staging accuracy 
could be 64% compared to Dukes’ classification in an early 
study.33 Combining with MDCT, the overall accuracy of the 
evaluation of local invasion could be 94.1%, and the accuracy 
of diagnosis for node was 80.5%.18 Nevertheless, this technique 
also has its limitations, requiring specific equipment for colon 
distension with carbon dioxide.
If we compare MDCT with water enema and MDCT 
with air, which would acquire higher accuracy? Stabile et al 
did this head-to-head comparison study with 70 patients who 
were divided into two groups;34 the results reported that the 
overall diagnostic accuracy of MDCT with water and with air 
were 68.6%, 62.8%, respectively. Regarding the T staging, the 
accuracies were 88.6% for water and 80% for air colonography. 
With regards to the N staging, the accuracies were 77.1% and 
74.3% for water and air MDCT colonography, respectively.34 
This may somehow support the water enema as a better bowel 
distension method.
d I A g n o s t I c  A c c u r A c y  
o f  c t  I n  n  s t A g I n g
The evaluation of lymph node status is essential before 
making treatment plan, especially for rectal cancer patients. 
Those with evidence of lymph node metastasis will require 
adjuvant therapy to reduce the possibility of local recurrence.
According to the TNM classification, the criteria of N stag-
ing modified by Burton et al are as follows,16 N0: No lymph 
node >1 cm and no abnormal clustering. N1: 1-3 lymph nodes 
>1 cm, or abnormal clustering of 3 or more normal-sized 
lymph nodes. N2: More than 3 lymph nodes >1 cm.
The accuracy of CT in N staging was not as good as that of 
T staging. In the early studies in 1980’s,22,23 the low sensitivity 
(from 26% to 73%) and the low specificity (from 58% to 96%) 
came from the conventional CT with 10 mm section thickness, 
while the sensitivity (from 86% to 89%) and the specificity 
(from 75% to 82%) of the studies in 2000’s with MDCT of 
1-3 mm section thickness demonstrate some improvement,19,35 
though the results were not statistically significant, compared 
with the results in 1980’s. The factors which may improve the 
accuracy of T staging in CT were also important in the evalua-
tion of N staging, including the section thickness of CT, the use 
of MDCT, the technique of multiplanar reformations.9,17,26,35 
However, CT with water enema or air insufflation did not 
make significant improvement in pretreatment N staging of 
colorectal cancer.15,17,25,30,31,34
Modern MDCT has been used to identify lymph nodes 
of more than 5 mm in diameter.36 Most studies of colorectal 
cancer pretreatment staging use lymph node size as the cri-
terion for predicting nodal involvement.37-39 Unfortunately, 
there is evidence to demonstrate that nodal size is poor at 
differentiating benign from metastatic lesions.40-44 Also there 
is little agreement on the critical cut-off diameter to determine 
whether lymph nodes are involved. A specific threshold value 
was difficult to establish to distinguish benign from malignant 
nodes, as a low size threshold could gain a higher sensitivity 
with low specificity, and a higher size threshold lowered the 
sensitivity but improved the specificity. On the other hand, 
microscopic tumor involvement can be present in non-enlarged 
lymph nodes and benign reactive nodes can sometimes be 
enlarged. Dworak et al examined 12,759 nodes histologically 
following resection. They found that the mean diameter of 
benign lymph nodes was 3.34 mm compared with 3.84 mm for 
the metastatic nodes.45 Thus, the nodal size would be a poor 
discriminator of colorectal metastatic nodal status.
Although CT could not provide an ideal accuracy of N 
staging, this was not a significant clinical problem for colon 
cancer, because regional enlarged lymph node would not be 
a contraindication to surgery, and lymph node sampling is 
routinely performed at surgery. But for rectal cancer, if we 
can precisely detect the involved lymph nodes, we can make a 
better selection among surgery, chemotherapy or radiotherapy. 
Thus, the role of pretreatment staging is relatively more impor-
tant, luckily MRI and ERUS could help increase the accuracy 
of N staging, which will be discussed below.
c o M p A r I s o n  w I t h  o t h e r  
I M A g I n g  M o d A l I t I e s
1 .  p e t  I s  n o t  M o r e  A c c u r A t e  t h A n  c t
PET/CT has been allowed for better staging in a number 
of tumors, and resulted in clinical management variations in 
clinical practice.46-49 Currently, about colorectal cancer, PET/
CT is recommended only in pretreatment staging prior to 
metastasectomy and in the assessment of suspected recurrence.
In T staging of colorectal cancer, PET/CT was inappropri-
ate to determine the exact depth of the primary tumor inva-
sion because of its limited resolution.50 Thus, the accuracy of 
T staging of colorectal cancer by PET/CT was almost totally 
reliant on CT and PET could hardly be helpful for T staging.
In N staging of colorectal cancer, PET/CT could not 
improve the accuracy of colorectal cancer pretreatment N 
staging compared with conventional CT scan, but may bring 
some false-negative information. Like the result of a study 
performed by Cipe G et al,50 after comparing with the histo-
pathological results, the accuracy of MDCT in N staging was 
higher than PET/CT. The sensitivity of PET/CT was as low as 
52.38%, which meant that it missed many metastatic lymph 
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nodes and underestimated N stage in many patients. Several 
other studies reported comparable results of PET/CT, show-
ing low sensitivity (29–37%) and high specificity (83–96%).51,52 
Thus, for the N staging of colorectal cancer, PET/CT could 
not offer much help, though the accuracy of MDCT is still not 
so ideal for N staging.
Some recent studies demonstrated that routine use of PET/
CT for preoperative staging did not impact disease manage-
ment for most of the colorectal cancer patients after comple-
tion of standard work-up, including physical examination, 
ERUS, CT of the abdomen and pelvis, and chest CT or chest 
X-ray.50,53 With the rapid development of CT, MRI and ERUS, 
and considering the cost-effectiveness, PET/CT is not recom-
mended routinely for pretreatment staging for most of the 
colorectal patients after the completion of standard work-up.
2 .  c t  I n  l o c A l  s t A g I n g  o f  r e c t A l  c A n c e r 
I s  n o t  s o  g o o d  A s  M r I  o r  e r u s
In the American College of Radiology appropriateness 
criteria,7 ERUS was recommended as the first choice for as-
sessment of rectal wall involvement level of small or superficial 
rectal cancer, and for large or advanced rectal cancer, CT and 
MRI were recommended in the first place.
A meta-analysis comparing ERUS, CT, and MRI pretreat-
ment staging accuracy for rectal cancer,51 showed that for 
T2, T3 staging, ERUS achieved significantly higher accuracy 
than MRI and CT. While evaluating T4 or N stage, the results 
were comparable. Results from other studies were similar, 
also showing that ERUS was better than CT for preoperative 
assessment of depth of invasion.36,54,55
However, ERUS also has its own limitations. One is that 
it depends greatly on the operators’ experience, being associ-
ated with a steep learning curve.56-58 Tumors exceeding 50 
mm in length could not be reliably measured by ERUS due 
to the limit in the length of each recording. Another problem 
may be stenotic lesions, which would limit access of the ultra-
sound probe. Almost all the deficiencies of ERUS could be 
overcome by CT.
With the help of diffusion-weighted magnetic resonance 
imaging (DWI), gadolinium-based contrast agents and tumor 
or nodal morphology with higher resolution, MRI images were 
more distinct than CT images on local staging of rectal cancer 
after comparing with histopathological results.42,51,59,60
MRI either with phased array coil or with endorectal coil 
can distinguish various layers of the rectal wall. As the appar-
ent limitations, such as high cost, limited field of examination, 
discomfort of insertion and insertion failure rate, which could 
be up to 40%, MRI with endorectal coil was not commonly 
used. Thus, MRI with phased array coil may be more accept-
able than MRI with endorectal coil. Although the accuracy 
of local assessment for rectal cancer is better than CT, the 
time-consuming and limited scan area defects of MRI make 
it not so commonly used as CT.
In summary, for rectal cancer, MRI and ERUS could be 
used under different conditions, and both of them are better 
than CT for the pretreatment local staging. However, CT 
could be less time-consuming and more suitable than MRI 
for claustrophobic patients or elder patients who cannot hold 
their breath for long time.
c o n c l u s I o n
Many modalities are available for the pretreatment staging 
of colorectal cancer. CT is the most practical and convenient 
method, and CT is the most common choice in clinical prac-
tice for pretreatment evaluation of colorectal cancer except 
that in the local staging of rectal cancer one may select MRI 
or ERUS as the modality of choice. With the rapid develop-
ment of CT technique, MDCT with thinner section thickness 
and multiplanar reformations could provide higher resolution 
images and make more accurate pretreatment staging. When 
combining MDCT with the water enema or air insufflation, we 
may achieve higher sensitivity and specificity for T staging, but 
not for N staging. For N staging, the accuracy of CT was not as 
good as that in T staging. Considering the cost-effectiveness, 
PET/CT is not recommended for pretreatment staging for 
most of the colorectal cancer patients after the completion of 
standard work-up, and PET/CT may even bring some false-
negative information in N staging. Finally, more large scale 
trials are needed on tumor staging accuracy with MDCT and/
or with other new imaging techniques.
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